Search Results - "Leckey, Claire"
-
1
Mass spectrometry analysis of tau and amyloid‐beta in iPSC‐derived models of Alzheimer’s disease and dementia
Published in Journal of neurochemistry (01-10-2021)“…Induced pluripotent stem cell (iPSC) technology enables the generation of human neurons in vitro, which contain the precise genome of the cell donor, therefore…”
Get full text
Journal Article -
2
Neurofilament light chain: defining the analyte
Published in Brain communications (2022)“…This scientific commentary refers to ‘A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease’ by…”
Get full text
Journal Article -
3
A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer’s Disease Diagnosis Using Targeted Proteomics and Machine Learning
Published in International journal of molecular sciences (01-09-2023)“…As disease-modifying therapies are now available for Alzheimer’s disease (AD), accessible, accurate and affordable biomarkers to support diagnosis are urgently…”
Get full text
Journal Article -
4
SILK studies — capturing the turnover of proteins linked to neurodegenerative diseases
Published in Nature reviews. Neurology (01-07-2019)“…Alzheimer disease (AD) is one of several neurodegenerative diseases characterized by dysregulation, misfolding and accumulation of specific proteins in the…”
Get full text
Journal Article -
5
CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice
Published in Brain (London, England : 1878) (01-10-2019)“…Neuroinflammation and microglial activation are significant processes in Alzheimer's disease pathology. Recent genome-wide association studies have highlighted…”
Get full text
Journal Article -
6
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes
Published in Brain communications (01-01-2021)“…Abstract Preliminary pathological and biomarker data suggest that SARS-CoV-2 infection can damage the nervous system. To understand what, where and how damage…”
Get full text
Journal Article -
7
CSF neurofilament light chain profiling and quantitation in neurological diseases
Published in Brain communications (2024)“…Neurofilament light chain is an established marker of neuroaxonal injury that is elevated in CSF and blood across various neurological diseases. It is…”
Get full text
Journal Article -
8
Stable Isotope Labeling Kinetics (SILK) tracing of neurofilament light in stem cell‐derived neurons
Published in Alzheimer's & dementia (01-12-2022)“…Background Neurofilament light polypeptide (NfL) is a basic component of intermediate filaments in neurons that is released from damaged and/or degenerated…”
Get full text
Journal Article -
9
Stable Isotope Labelling Kinetics tracing of Neurofilament Light in stem cell‐derived neurons and humans
Published in Alzheimer's & dementia (01-12-2023)“…Background Neurofilament light (NfL) is a neuronal cytoskeletal protein that is released into the extracellular environment from degenerated axons. As such,…”
Get full text
Journal Article -
10
Inflammatory biomarkers in Alzheimer's disease plasma
Published in Alzheimer's & dementia (01-06-2019)“…Plasma biomarkers for Alzheimer's disease (AD) diagnosis/stratification are a “Holy Grail” of AD research and intensively sought; however, there are no…”
Get full text
Journal Article -
11
Choroid plexus protein turnover in human choroid plexus organoids recapitulates turnover in humans measured using stable isotope labeling kinetics (SILK)
Published in Alzheimer's & dementia (01-12-2023)“…Background The choroid plexus secretes protein‐rich cerebrospinal fluid (CSF). CSF turnover is a key mechanism for protein clearance. Neurodegenerative…”
Get full text
Journal Article -
12
Investigating changes in the proteostasis capabilities of iPSC‐neurons during development and in FTD using iPSC‐neurons with MAPT mutations
Published in Alzheimer's & dementia (01-12-2021)“…Background Mutations in microtubule‐associated protein tau (MAPT) gene are causative of Frontotemporal Dementia (FTD). Many of the features associated with the…”
Get full text
Journal Article -
13
Development of a targeted proteomic assay for the quantitation of neurofilament light in cerebrospinal fluid: Correlation with Simoa‐based quantitation across neurodegenerative diseases and centres
Published in Alzheimer's & dementia (01-12-2023)“…Background Cerebrospinal fluid (CSF) neurofilament light (NfL) is a dynamic biomarker of neurodegeneration that is used for supporting clinical diagnosis and…”
Get full text
Journal Article -
14
Complement biomarkers in Alzheimer's disease
Published in Molecular immunology (01-09-2017)Get full text
Journal Article -
15
P1‐261: DEVELOPMENT OF A UNIFIED ‐OMIC PREPARATION METHODOLOGY: AN ALTERNATIVE, NON‐IP APPROACH TO TARGETED LC‐MS/MS DETECTION OF SECRETED AMYLOID‐β PEPTIDES IN CEREBROSPINAL FLUID AND IPSC‐DERIVED FAMILIAL ALZHEIMER'S DISEASE MODELS
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article -
16
NEUROFILAMENT LIGHT IN ISOPOTENTIAL STEM CELL-DERIVED NEURONS WITH FAMILIAL AD MUTATIONS AS A MARKER OF NEURODEGENERATION
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article -
17
DEVELOPMENT OF A UNIFIED -OMIC PREPARATION METHODOLOGY: AN ALTERNATIVE, NON-IP APPROACH TO TARGETED LC-MS/MS DETECTION OF SECRETED AMYLOID-β PEPTIDES IN CEREBROSPINAL FLUID AND IPSC-DERIVED FAMILIAL ALZHEIMER’S DISEASE MODELS
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article -
18
P2‐244: NEUROFILAMENT LIGHT IN ISOPOTENTIAL STEM CELL‐DERIVED NEURONS WITH FAMILIAL AD MUTATIONS AS A MARKER OF NEURODEGENERATION
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article -
19
EX-VIVO VALIDATION OF PLASMA PROTEIN FIBRINOGEN GAMMA
Published in Alzheimer's & dementia (01-07-2017)Get full text
Journal Article -
20
Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease
Published in Journal of neuroinflammation (09-04-2023)“…Neuroinflammation is an important component of many neurodegenerative diseases, whether as a primary cause or a secondary outcome. For that reason, either as…”
Get full text
Journal Article